Last Updated:

Monday, March 27, 2023

8:38 AM

USA

CytoDyn

CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).

CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).

Newsroom